Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06330844 · ClinicalTrials.gov registry record · NA

Race-Based Stress and Cognitive Training for MCI

A NA study of Mild Cognitive Impairment, sponsored by Rosalind Franklin University of Medicine and Science.

Recruiting
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT06330844: Recruiting NA study of Mild Cognitive Impairment, sponsored by Rosalind Franklin University of Medicine and Science.

NCT06330844 is a NA study of Mild Cognitive Impairment that is actively recruiting participants, run by Rosalind Franklin University of Medicine and Science. The registered enrollment target is 9 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06330844, a NA study of Mild Cognitive Impairment, is actively recruiting participants, sponsored by Rosalind Franklin University of Medicine and Science.

RECRUITING
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

This a two phase project that aims to pilot a new adaptation (Phase 1) of Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT; an originally VA-based cognitive rehabilitation manualized intervention for older adults with MCI, with a focus on the impact of stress on cognitive functioning; that integrates components from the Race Based Stress and Empowerment (RBSE) group for an increased focus on race-based stress and discrimination for racial minority older adults (i.e., RBSEF-CCT-MCI). In a pilot open trial, 75-150 participants will receive group-based intervention for 8 weeks, with 8-10 participants per group. Following the pilot study, the investigators will complete a randomized controlled trial (RCT) (Phase 2) to compare the efficacy of the RBSEF-CCT-MCI with the ME-CCT. In the RCT, 75-150 participants will be randomized into either 1) The active control group, who will complete the original, ME-CCT training program, or 2) The experimental group, who will complete the newly developed RBSE-CCT-MCI. Both research groups will complete the interventions for 8 weeks, with 8-10 participants per group. Hypothesis: Participation in this newly developed/updated intervention (i.e., RBSEF-CCT-MCI) will result in improvements in both (a) subjective and (b) objective cognitive functioning, and (c) self-reported mental health symptoms.

Primary Outcome

Assessed by the California Verbal Learning Test- Second Edition (CVLT-II)

Conditions Studied

Mild Cognitive Impairment

Interventions

  • BEHAVIORAL Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment (RBSEF-CCT-MCI)
  • BEHAVIORAL Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT)

Study Locations (1)

Illinois

  • Rosalind Franklin University of Medicine and Science - Chicago

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2025-03-01
Est. Completion 2028-03-15
Phase NA
Rosalind Franklin University of Medicine and Science

8 total trials

What NCT06330844 shows while recruiting

NCT06330844 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment (RBSEF-CCT-MCI) is the first listed.

NCT06330844 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06330844 about?

NCT06330844 is a clinical study titled "Race-Based Stress and Cognitive Training for MCI". This a two phase project that aims to pilot a new adaptation (Phase 1) of Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT; an originally VA-based cognitive rehabilitation manualized intervention for older adults with MCI, with a focus on the impact of st...

What is the current status of trial NCT06330844?

This trial is currently recruiting. It is a NA study. The enrollment target is 9 participants. The study started on 2025-03-01. Estimated completion is 2028-03-15.

What conditions does trial NCT06330844 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment.

What interventions are being tested in trial NCT06330844?

The interventions under investigation include: Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment (RBSEF-CCT-MCI) (BEHAVIORAL), Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06330844?

This trial is sponsored by Rosalind Franklin University of Medicine and Science, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06330844 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06330844's enrollment target sits among peer trials

9 201st of 205 higher than 5 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06330844

Source: ClinicalTrials.gov NCT06330844, the US trial registry maintained by the National Library of Medicine. NCT06330844 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.